Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer. | Front Endocrinol (Lausanne) | 2022 | 36686485 | PubTator, text mining | PubMed |
| Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women. | Front Genet | 2022 | 36685821 | PubTator, text mining | PubMed |
| Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microenvironment of long-term survivors. | Front Immunol | 2022 | 36685537 | PubTator, text mining | PubMed |
| Advancements in Cancer Immunotherapies. | Vaccines (Basel) | 2022 | 36679904 | PubTator, text mining | PubMed |
| A Novel Prognostic Prediction Model Based on Pyroptosis-Related Clusters for Breast Cancer. | J Pers Med | 2022 | 36675729 | PubTator, text mining | PubMed |
| Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets. | Mar Drugs | 2022 | 36662197 | PubTator, text mining | PubMed |
| Methylation-based epigenetic studies and gene integration analysis of preeclampsia. | Ann Transl Med | 2022 | 36660680 | PubTator, text mining | PubMed |
| Identification of immune-related genes and development of a prognostic model in mantle cell lymphoma. | Ann Transl Med | 2022 | 36660618 | PubTator, text mining | PubMed |
| Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences. | Explor Target Antitumor Ther | 2022 | 36654819 | PubTator, text mining | PubMed |
| Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study. | J Hematol | 2022 | 36632577 | PubTator, text mining | PubMed |
| Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders. | Front Oncol | 2022 | 36620555 | PubTator, text mining | PubMed |
| A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A. | J Clin Med | 2022 | 36614994 | PubTator, text mining | PubMed |
| Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool. | Int J Mol Sci | 2022 | 36614080 | PubTator, text mining | PubMed |
| In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies. | Cancers (Basel) | 2022 | 36612228 | PubTator, text mining | PubMed |
| Primary meningeal central nervous system lymphoma: A case report and literature review. | Medicine (Baltimore) | 2022 | 36596043 | PubTator, text mining | PubMed |
| Aberrant B-Cell Activation in Systemic Lupus Erythematosus. | Kidney Dis (Basel) | 2022 | 36590680 | PubTator, text mining | PubMed |
Salvage Using Polatuzumab Vedotin Based Therapy in Relapsed Refractory Large B-Cell Lymphomas: Early Experience from a Real-World Middle-Income Setting Using Named-Patient Compassionate Access Program. | Indian J Hematol Blood Transfus | 2022 | 36590655 | PubTator, text mining | PubMed |
| Insights into the tumor microenvironment of B cell lymphoma. | J Exp Clin Cancer Res | 2022 | 36578079 | PubTator, text mining | PubMed |
| Aberrant expression of CD5 in a case of B acute lymphoblastic leukemia positive Philadelphia chromosome. | Tunis Med | 2022 | 36571758 | PubTator, text mining | PubMed |
| Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis. | Front Immunol | 2022 | 36569924 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=47